Abstract:Abstract Abstract 4798 Background: Acute monocytic leukemia (M5) is one kind of acute leukemia with poor prognosis, which has the characterization of high number of white blood cells, high risk of extramedullary metastasis and abnormal chromosome karyotype. Objective: To analyze clinical characterization and prognostic factors of adult acute monocytic leukemia. Methods: Clinical data of 144 patients diagnosed between Jan 1st 2006 and Dec 31 2010 were collected. Clinical manifestation, cytogenetics, immunophenotyping and minimal residual disease (MRD) were analyzed respectively. The numeration data was tested by χ2 test, while the measurement data by Levene test to variance homogeneity and by T test to the mean difference. The data were analyzed by SPSS 17.0. Results: 81.9% of 144 patients reached complete remission. 27.5% patients were abnormal in cytogenetics, including +8, −5/del (5q), −7/del (7q). Patients were divided into three groups according to chromosome karyotype. Intermediate prognostic group has better OS and DFS than poor prognostic group (P<0.05). 26 patients treated with SCT.These patients have higher OS rate for one year and low relapse rate than those who did not receive SCT.CR rate for old patients(≥55) and young patients (<55) were 69.4% and 86.1% respectively. Old patients had shorter OS and DFS than young patients, but no singnificant difference in FAB type, number of white blood cell and immunophenotyping. Old patients occur chromosome abnormalities more frequently than young patients. Relapse rate is 20.7% in MRD+ group versus 11.5% in MRD- group. Multivariate COX analysis showed that chromosome karyotype and MRD had most significant correlation with relapse. Conclusion: Chromosome karyotype, age, therapy, MRD were all prognostic factors of M5. Chromosome karyotype and MRD had most important significance in prognosis. Disclosures: No relevant conflicts of interest to declare.

myelogenous leukemia Clonal evolution and devolution after chemotherapy in adult acute

Clonal Evolution And Devolution Following Chemotherapy In Adult Acute Myelogenous Leukemia

Clinical Characterization and Prognostic Factors of 144 Adult Acute Monocytic Leukemia

Clonal Evolution and Devolution after Chemotherapy in Adult Acute Myelogenous Leukemia

Clonal Evolution in Leukemia: Preleukemia, Evolutionary Models, and Clinical Implications

blown leukemia chronic myeloid leukemia and their contribution to inducing murine Functional features of RUNX 1 mutants in acute transformation

Research of gene mutation in acute myeloid leukemia: development and prospect

Acute myeloid leukemia: introduction to a series highlighting progress and ongoing challenges

Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?

The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: From biology to therapeutic targeting

Evolving Horizons in Pediatric Leukemia: Novel Insights, Challenges, and the Journey Ahead

Advances in pathogenesis research and challenges in treatment development for acute myeloid leukemia

Advances in acute myeloid leukemia

Clonal Evolution in 207 Cases of Refractory or Relapsed Acute Myeloid Leukemia

Acute Leukemia Transformed from Myeloproliferative Neoplasms with Philadelphia Chromosome-Negative:Report of Eight Cases and Review of Literature

Cmar_a_199817 3187..3196

Malignant progression of pre-leukemic disorders

AML 1-ETO and its implication in leukemogenesis by EEN fusion partner MLL Aberrant transcriptional regulation of the

Early drivers of clonal hematopoiesis shape the evolutionary trajectories of acute myeloid leukemia

Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics

Leukemic stem cells and advances in hematopoietic stem cell transplantation for acute myeloid leukemia: a narrative review of clinical trials